ArticlePharmaceutics2022

Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles.

José M Espejo-Román et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.